拉氧头孢钠对改善盆腔炎患者下腹痛及生活质量的效果  

Effect of latamoxef sodium for treating patients with pelvic inflammatory disease on their lower abdominal pain and quality of life

作　　者：成定菊 连荣丽 韩建龙 王熊 CHENG Dingju;LIAN Rongli;HAN Jianlong;WANG Xiong(Ankang Maternal and Child Health Care Hospital,Ankang,Shanxi Province,725000)

机构地区：[1]陕西省安康市妇幼保健院,725000

出　　处：《中国计划生育学杂志》2024年第12期2750-2753,共4页Chinese Journal of Family Planning

摘　　要：目的:分析注射用拉氧头孢钠对改善盆腔炎患者下腹痛及生活质量的效果。方法:选取2022年1月-2023年12月于本院诊断的盆腔炎患者104例,根据治疗方案不同分为对照组和观察组各52例,分别给予甲硝唑以及拉氧头孢钠治疗,采用视觉模拟量表(VAS)、抑郁自评量表(SDS)、焦虑自评量表(SAS)和汉化版简明健康调查表(SF-36)评估患者治疗后疼痛及生活质量改善情况。结果:治疗10天后,观察组临床有效率(92.3%)高于对照组(76.9%),两组VAS评分均较治疗前降低,且观察组VAS评分(0.63±0.66分)低于对照组(1.35±0.84分);两组SDS及SAS评分均较治疗前降低,且观察组SDS(36.63±4.68分)、SAS(35.54±4.08分)评分低于对照组(41.65±5.22分、39.77±4.47分);两组SF-36中躯体健康总测量(PCS)、心理健康总测量(MCS)评分均较治疗前升高,且观察组PCS(77.37±4.64分)、MCS(80.12±3.53分)评分高于对照组(73.40±4.86分、74.56±3.44分)(均P<0.05)。结论:拉氧头孢钠治疗盆腔炎疗效确切,且能有效降低患者下腹痛程度并提高生活质量。Objective:To analyze the effect of latamoxef sodium for treating patients with pelvic inflammatory disease on their lower abdominal pain and quality of life.Methods:A total of 104 patients with pelvic inflammatory disease who were diagnosed in the hospital were selected as the study subjects and were divided into two groups(52 cases in each group)according to the different treatment methods from January 2022 to December 2023.The patients in the control group were given the treatment of metronidazole and the patients in the observation group were given the treatment of latamoxef sodium.Visual analogue scale(VAS),self-rating depression scale(SDS),self-rating anxiety scale(SAS)and Chinese version of brief health questionnaire(SF-36)were used to assess the situations of the lower abdominal pain and the improvement of the quality of life of the patients in the two groups.Results:After lo days of the treatment,the clinical effective rate(92.3%)of the patients in the observation group was significantly higher than that(76.9%)of the patients in the control group.The VAS score of the patients in the two groups after treatment had decreased significantly,and which(0.63±0.66 points)of the patients in the observation group was significantly lower than that(1.35±0.84 points)of the patients in the control group.The scores of SDS(36.63±4.68 points)and SAS(35.54±4.08 points)of the patients in the observation group were significantly lower than those(41.65±5.22 points and 39.77±4.47 points)of the patients in the control group.The scores of physical component summary(PCS)and mental component summary(MCS)in SF-36 of the patients in the two groups after treatment had decreased significantly,and which(77.37±4.64 points and 80.12±3.53 points)of the patients in the observation group were significantly higher than those(73.40±4.86 points and 74.56±3.44 points)of the patients in the control group(all P<0.05).Conclusion:Latamoxef sodium has definite effectiveness in the treatment of the patients with pelvic inflammatory disease,

关 键 词：盆腔炎 拉氧头孢钠 下腹痛 生活质量 治疗效果 

分 类 号：R711.33[医药卫生—妇产科学]